Total Payments
$1.0M
2024 Payments
$195,069
Companies
56
Transactions
1,500
Medicare Patients
3,342
Medicare Billing
$630,704
Payment Breakdown by Category
Other$822,567 (79.7%)
Consulting$121,625 (11.8%)
Travel$42,029 (4.1%)
Food & Beverage$36,725 (3.6%)
Research$7,000 (0.7%)
Education$1,710 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $813,238 | 344 | 78.8% |
| Consulting Fee | $121,625 | 47 | 11.8% |
| Travel and Lodging | $42,029 | 195 | 4.1% |
| Food and Beverage | $36,725 | 891 | 3.6% |
| Honoraria | $8,329 | 3 | 0.8% |
| Unspecified | $7,000 | 2 | 0.7% |
| Education | $1,710 | 17 | 0.2% |
| Grant | $1,000 | 1 | 0.1% |
Payments by Type
General
$1.0M
1,498 transactions
Research
$7,000
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $189,859 | 222 | $0 (2024) |
| EMD Serono, Inc. | $163,286 | 214 | $0 (2024) |
| Biogen, Inc. | $122,714 | 136 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $84,582 | 136 | $0 (2024) |
| TG Therapeutics, Inc. | $62,886 | 50 | $0 (2024) |
| Allergan, Inc. | $62,302 | 66 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $61,823 | 78 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $60,086 | 34 | $0 (2024) |
| Acorda Therapeutics, Inc | $59,024 | 54 | $0 (2023) |
| MDD US Operations, LLC | $44,261 | 76 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $195,069 | 302 | EMD Serono, Inc. ($50,436) |
| 2023 | $163,810 | 312 | Neurocrine Biosciences, Inc. ($36,385) |
| 2022 | $177,956 | 208 | E.R. Squibb & Sons, L.L.C. ($42,370) |
| 2021 | $158,338 | 138 | EMD Serono, Inc. ($43,260) |
| 2020 | $88,984 | 105 | Biogen, Inc. ($24,154) |
| 2019 | $147,265 | 222 | Acorda Therapeutics, Inc ($37,325) |
| 2018 | $98,232 | 191 | Neurocrine Biosciences, Inc. ($27,954) |
| 2017 | $2,003 | 22 | GENZYME CORPORATION ($1,153) |
All Payment Transactions
1,500 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/20/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Neurology | ||||||
| 12/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Immunology | ||||||
| 12/18/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,463.00 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $69.68 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.43 | General |
| 12/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.73 | General |
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $26.80 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $122.46 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: AMANTADINE | ||||||
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | Cash or cash equivalent | $8.33 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Honoraria | Cash or cash equivalent | $3,029.00 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Travel and Lodging | In-kind items and services | $33.50 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.76 | General |
| 11/25/2024 | EMD Serono, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.47 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $7,000 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,101 | 18,450 | $308,122 | $201,801 |
| 2022 | 17 | 938 | 23,147 | $319,454 | $202,954 |
| 2021 | 15 | 666 | 16,914 | $232,882 | $122,953 |
| 2020 | 13 | 637 | 14,987 | $181,558 | $102,996 |
Total Patients
3,342
Total Services
73,498
Medicare Billing
$630,704
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 45 | 17,101 | $118,568 | $77,195 | 65.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 325 | 504 | $68,145 | $44,828 | 65.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 115 | 150 | $27,521 | $19,099 | 69.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 71 | 71 | $15,774 | $11,268 | 71.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $13,523 | $9,677 | 71.6% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 53 | 55 | $15,354 | $8,645 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 130 | $12,210 | $8,449 | 69.2% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 22 | 38 | $7,055 | $3,787 | 53.7% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 32 | 32 | $8,376 | $3,506 | 41.9% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 121 | 132 | $4,649 | $3,398 | 73.1% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 13 | 13 | $4,357 | $3,167 | 72.7% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 12 | 24 | $3,329 | $2,346 | 70.5% |
| 92548 | Test for balance and posture | Office | 2023 | 58 | 60 | $3,408 | $2,106 | 61.8% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 12 | 19 | $2,444 | $1,634 | 66.9% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 13 | 29 | $1,748 | $1,381 | 79.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $1,663 | $1,315 | 79.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 45 | 19,030 | $125,258 | $84,897 | 67.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 420 | $57,908 | $38,262 | 66.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 112 | 131 | $24,319 | $17,469 | 71.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 80 | 80 | $18,175 | $13,525 | 74.4% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 58 | 58 | $15,996 | $9,760 | 61.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $11,894 | $8,658 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 113 | $10,828 | $7,552 | 69.7% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 21 | 43 | $7,621 | $4,477 | 58.7% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 17 | 17 | $7,985 | $4,134 | 51.8% |
About Dr. Joash Lazarus, M.D
Dr. Joash Lazarus, M.D is a Neurology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1720374754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joash Lazarus, M.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $195,069 received in 2024. These payments were reported across 1,500 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($813,238).
As a Medicare-enrolled provider, Lazarus has provided services to 3,342 Medicare beneficiaries, totaling 73,498 services with total Medicare billing of $630,704. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Atlanta, GA
- Active Since 06/28/2011
- Last Updated 05/15/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1720374754
Products in Payments
- INGREZZA (Drug) $185,376
- Mavenclad (Drug) $126,465
- NUPLAZID (Drug) $82,687
- BOTOX (Biological) $82,683
- ZEPOSIA (Drug) $74,546
- BRIUMVI (Drug) $58,696
- Austedo XR (Drug) $58,154
- INBRIJA (Drug) $52,821
- TYSABRI (Biological) $47,126
- VUMERITY (Drug) $36,310
- MAVENCLAD (Drug) $33,676
- GOCOVRI (Drug) $19,284
- APOKYN (Drug) $18,694
- Gocovri (Drug) $16,798
- UBRELVY (Drug) $14,414
- TECFIDERA (Drug) $13,493
- AUBAGIO (Drug) $7,822
- Tysabri (Biological) $6,630
- Xadago (Drug) $6,525
- OCREVUS (Biological) $6,258
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlanta
Robert Gilbert, M.d, M.D
Neurology — Payments: $946,678
Neurology $946,678
Douglas Stuart, M.d, M.D
Neurology — Payments: $807,499
Neurology $807,499
Frank Berenson, Md, MD
Neurology — Payments: $628,973
Neurology $628,973
Julio Flamini, M.d, M.D
Neurology — Payments: $554,096
Neurology $554,096
Lawrence Seiden, M.d, M.D
Neurology — Payments: $318,322
Neurology $318,322
Andrei Serbanescu, M.d, M.D
Neurology — Payments: $317,980
Neurology $317,980